CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
ExpreS2ion Biotech Holding AB Company Snapshot
ExpreS2ion Biotech Holding AB operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares ExpreS2ion Biotech Holding AB with three other pharmaceutical manufacturers in Europe: Erytech Pharma SA of France (2018 sales of 4.45 million Euro [US$4.97 million] of which 100% was Pharmacy), Nuevolution AB (publ) (10.97 million Swedish Kronor [US$1.14 million] ), and Oncoarendi Therapeutics SA which is based in Poland (3,000.00 Polish New Zlotys [US$782.67 ] ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
ExpreS2ion Biotech Holding AB
  Stock Performance Chart for ExpreS2ion Biotech Holding AB
 
  Stock Data: Recent Stock Performance:
  Current Price (10/18/2019): 5.12
(Figures in Swedish Kronor)
1 Week 27.0%   13 Weeks 12.5%  
4 Weeks 1.2%   52 Weeks -42.5%  
 
ExpreS2ion Biotech Holding AB Key Data:
  Ticker: EXPRS2 Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 8,868,000
(Year Ending Jan 2019).
Employees: N/A
  Currency: Swedish Kronor Market Cap: 69,642,317
  Fiscal Yr Ends: December Shares Outstanding: 13,602,015
  Share Type: Aktie Closely Held Shares: N/A
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.